Marca Nominativa depositada no INPI em 15/07/2020 por MABLINK BIOSCIENCE, processo nº 501564321, nas classes 01, 05, 40, 42, 44. Registro em vigor até 15/07/2030.
| Número do processo | 501564321 |
|---|---|
| Situação | Registro de marca em vigor (Madri) |
| Apresentação | Nominativa |
| Natureza | Madri Produto/Serviço |
| Data do depósito | 15/07/2020 |
| Data da concessão | 01/02/2022 |
| Vigência até | 15/07/2030 |
| Titular | MABLINK BIOSCIENCE |
| CNPJ/CPF do titular | — |
| UF · País | — · FR |
Chemical, biochemical, biological and biotechnological preparations; chemical substances for the manufacture of pharmaceutical products; chemical substances for tethering molecules, in particular chemical substances for tethering molecules for cancer therapy, for research in active substances and medicines; chemical substances for the formation of antibody conjugates; chemical reagents for scientific purposes other than for medical or veterinary purposes; reagents for scientific or medical research; chemical, biochemical and biological reagents; chemicals for bioconjugation, reversible cysteine protection, surface modification, and the production of prodrugs; antibodies and antibody conjugates for scientific purposes, other than for medical or veterinary purposes; antibodies for scientific or medical research; molecules and biomolecules, especially reagents, antibody fragments, antibodies, all intended for fundamental research and development, medical research and scientific diagnosis; Diagnostic products for scientific or research use related to conjugated antibodies (medicines).;
Pharmaceutical preparations; pharmaceutical products, in particular for the prevention or treatment of human diseases; chemical, biological and biochemical products for medical and pharmaceutical use, especially, antibody-drug conjugates or any protein combined with a drug, a polynucleotide, another protein, a chemical entity, or another functional entity, or these products used as binders or fillers; pharmaceutical preparations, in particular bioconjugates, intended for the diagnosis and treatment of diseases; antibody products, especially, antibody or protein bioconjugates for the medical diagnosis and treatment of diseases, including antibody/protein drug conjugates, antibody/protein labeled conjugates and antibody/protein imaging agent conjugates; delivery devices for antibodies; molecules and biomolecules, especially, reagents, antibody fragments, antibodies, all intended for medical diagnosis and disease treatment; pharmaceutical products, preparations and medical articles, especially antibodies, antibody conjugates and active principles and antibody conjugates; chemical reagents for medical use, in particular chemical reagents to bind molecules for medical use; chemical reagents for the functionalization of biomolecules for medical use.;
Preparation, transformation, processing of biopharmaceutical materials and especially reagents, antibodies and conjugated antibodies; processing and transformation of biopharmaceutical materials on behalf of third parties; custom manufacturing of scientific, medical, chemical, biochemical and pharmaceutical products.;
Scientific research; biological and chemical research; biochemical research and development; research and development in the pharmaceutical, biomedical and biotechnological fields, especially research into antibodies, including conjugated antibodies; research and development in the fields of biological development and biomanufacturing; laboratory research, analysis, evaluation, development and clinical testing of therapeutic, preventive and diagnostic compositions and treatments; conducting scientific and medical research for third parties; consultancy in the field of pharmaceutical research, chemistry, biotechnology; custom synthesis of chemical substances; chemical and/or biological development services; services of a chemical and/or a biologist; chemical and biological laboratory services; laboratory services concerning the modification and production of reagents, antibodies and conjugated antibodies; research and development services in the field of reagent development and production of antibodies and conjugated antibodies; conducting chemical and/or biological analyses; customized design and development of chemical reagents, antibodies and conjugated antibodies; development of chemical substances, in particular chemical substances to tether molecules and in particular technological platforms in the form of or used for the creation or improvement of antibody-drug conjugates or any protein combined with a drug, a polynucleotide, another protein, a chemical entity or another functional entity intended for industry and science.;
Medical services; medical modification of antibodies; medical services in the field of personalized medicine; advice and information services with respect to biopharmaceutical products; pharmaceutical advice; consultancy services in the field of medicine.;
Receba um e-mail a cada novo despacho publicado na RPI para o processo 501564321 — exigência, oposição, deferimento, prazo de pagamento — e quando alguém depositar uma marca parecida.
Monitorar esta marca Ver marcas parecidas3 despacho(s) publicado(s) na Revista da Propriedade Industrial.